scorecardresearch
Follow Us:
Friday, June 18, 2021
Serum could begin Covovax trial on children in India next month

Serum could begin Covovax trial on children in India next month

Serum Institute of India (SII) is likely to begin clinical trials of Novavax’s Covid-19 vaccine candidate on children in July, sources at the Pune-based vaccine manufacturer said. The recombinant nanoparticle protein-based vaccine — NVX-CoV2373 — developed by the American biotechnology firm has been branded Covovax in India. SII, which is partnering with Novavax, expects to launch Covovax in India by September.

x
img
Anandiben Patel
Premium

‘Anti-conversion law not passed just like that...

New
Premium Stories Premium stands for original, cutting edge content from The Indian Express.
Signup for exclusive access.